Ads
related to: c4 corvette 1996 for sale cheap
Search results
Results From The WOW.Com Content Network
The Chevrolet Corvette (C4) is the fourth generation of the Corvette sports car, produced by American automobile manufacturer Chevrolet from 1983 until 1996. The convertible returned, as did higher performance engines, exemplified by the 375 hp (280 kW) LT5 found in the ZR1.
Chevrolet released the Grand Sport (GS) version in 1996 to mark the end of production of the C4 Corvette. The Grand Sport moniker was a nod to the original Grand Sport model produced in 1963. [35] The Grand Sport came only in Admiral Blue with a white stripe down the middle, black wheels, and two red stripes on the front left wheel arch. [61]
A second chassis, known as T711 used a Chevrolet Corvette C4-derived 5.7-liter naturally aspirated V8 developing 800 hp, and was campaigned by Lee Racing. The cars featured bodywork similar to a Chevrolet Corvette C4 at the front, with a long pontoon-style tail featuring Corvette tail lights. Large side intakes would feed the radiators while ...
For premium support please call: 800-290-4726 more ways to reach us
AOL latest headlines, entertainment, sports, articles for business, health and world news.
The C5 Corvette is widely considered a very reliable platform for a high-performing sports car (standard C5 coupe) and supercar (Z06). Common failure points on all C5 Corvettes include the hazard switch, fuel tank level sensors (requires cleaning due to dirty gas sulfur deposits), and steering column lock message (an aftermarket fix exists).
For the 4th generation (C4), the ZR1 was the top-tier package that was available from 1990 to 1995, with a special engine designed in partnership with Lotus, after General Motors acquired Group Lotus, and with the objective of creating the world's fastest production car.
By Steven Brill Letter From the Editors Backstage at Johnson & Johnson. On May 20, about 100 stock analysts gathered in the ballroom of the Hyatt Regency Hotel in New Brunswick, New Jersey, to hear good news from top executives at Johnson & Johnson: The company had 10 new drugs in the pipeline that might achieve more than a billion dollars in annual sales.